Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management Has $17.26 Million Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management lifted its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 117.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 200,000 shares of the company’s stock after buying an additional 108,000 shares during the period. VanEck Pharmaceutical ETF comprises approximately 2.8% of Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management’s investment portfolio, making the stock its 12th biggest position. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management’s holdings in VanEck Pharmaceutical ETF were worth $17,256,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of PPH. FMR LLC grew its holdings in VanEck Pharmaceutical ETF by 12.5% during the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock worth $181,000 after acquiring an additional 212 shares during the last quarter. Edge Financial Advisors LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the third quarter worth $263,000. Harbour Investments Inc. grew its stake in shares of VanEck Pharmaceutical ETF by 16.6% in the third quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock worth $325,000 after purchasing an additional 488 shares during the last quarter. Townsquare Capital LLC increased its holdings in VanEck Pharmaceutical ETF by 3.8% in the third quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock valued at $334,000 after purchasing an additional 130 shares during the period. Finally, Assetmark Inc. raised its position in VanEck Pharmaceutical ETF by 5.8% during the 3rd quarter. Assetmark Inc. now owns 6,491 shares of the company’s stock worth $617,000 after purchasing an additional 354 shares during the last quarter.

VanEck Pharmaceutical ETF Trading Up 1.1 %

NASDAQ PPH opened at $86.86 on Friday. The firm has a market capitalization of $585.44 million, a PE ratio of 21.04 and a beta of 0.72. The business’s 50-day moving average price is $87.62 and its two-hundred day moving average price is $91.99. VanEck Pharmaceutical ETF has a 12 month low of $83.74 and a 12 month high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently announced a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were issued a $0.411 dividend. The ex-dividend date of this dividend was Friday, December 27th. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.